Skip to content

Clinical trials

Phase 3 Diabetes Mellitus trials in the Philippines

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 3 Country / region: Philippines Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20051
20065
20081
20097
20111
20141
20171
20183

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated5
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S5
AstraZeneca4
Allergan3
GlaxoSmithKline3
Takeda2
Bristol-Myers Squibb1
Corbridge Group Philippines, Inc.1
Eli Lilly and Company1
Janssen Research & Development, LLC1
Phenomix1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus23
Diabetes Mellitus, Type 214
Gastroparesis3
Vomiting2
Acute Coronary Syndrome1
Asthma1
Coronary Artery Disease1
Diabetes Mellitus, Type 11
Dyslipidemias1
Glucose Intolerance1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.